Phosphorylated MED1 Links Transcription Recycling and Cancer Growth

Mediator 1 (MED1) phosphorylation increased during prostate cancer progression to the lethal phase, and pharmacological inhibition of cyclin-dependent kinase 9 decreased prostate tumor growth by decreasing MED1 phosphorylation and RNA polymerase II recycling.